Jennifer Taubert

Insider profile

Currently holds a position at Johnson & Johnson

Performance

Overall performance
2.6

Performance over holding periods
2.6
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Executive Vice President - Worldwide Chairman, Pharmaceuticals Johnson & Johnson July 2, 2018 -

Jennifer Taubert's trades of Johnson & Johnson's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
421.38
Quantity 39,805 -49.5%
Value US$4,986,070
Transaction date
Proposed sale
Price
180.11
Quantity 72,124
Value US$2,025,904
Transaction date
Sale
Price
26.17
Quantity 86,866 -6.6%
Value US$3,510,107
Transaction date
Proposed sale
Price
177.81
Quantity 56,471
Value US$10,040,904
Transaction date
Sale
Price
156.27
Quantity 59,397 -29.6%
Value US$9,281,969
Transaction date
Proposed sale
Price
156.25
Quantity 59,397
Value US$9,280,528
Transaction date
Sale
Price
176.78
Quantity 76,923 -37.8%
Value US$13,598,402
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-18 2026-08-17 S Sale
39,805 -49.5%
421.38
US$4,986,070
39,805 -49.5% 421.38 US$4,986,070
2026-08-17 2026-08-17 PrS Proposed sale
72,124
180.11
US$2,025,904
72,124 180.11 US$2,025,904
2025-09-05 2025-09-04 S Sale
86,866 -6.6%
26.17
US$3,510,107
86,866 -6.6% 26.17 US$3,510,107
2025-09-04 2025-09-04 PrS Proposed sale
56,471
177.81
US$10,040,904
56,471 177.81 US$10,040,904
2024-02-12 2024-02-09 S Sale
59,397 -29.6%
156.27
US$9,281,969
59,397 -29.6% 156.27 US$9,281,969
2024-02-09 2024-02-09 PrS Proposed sale
59,397
156.25
US$9,280,528
59,397 156.25 US$9,280,528
2022-11-23 2022-11-22 S Sale
76,923 -37.8%
176.78
US$13,598,402
76,923 -37.8% 176.78 US$13,598,402